PROTECT EVERY PATIENT Trademark
Trademark Overview
On Thursday, March 7, 2024, a trademark application was filed for PROTECT EVERY PATIENT with the United States Patent and Trademark Office. The USPTO has given the PROTECT EVERY PATIENT trademark a serial number of 98437686. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, September 20, 2024. This trademark is owned by Global Life Technologies Corp.. The PROTECT EVERY PATIENT trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Antiseptic solutions; Antiseptic nasal solutions
Pathogen colonization reduction consulting services; Staph aureus colonization risk mitigation services; Staph aureus colonization risk management services; MRSA/MSSA colonization risk mitigation services; Infection prevention and control consulting services; Healthcare quality and patient safety consulting services; Universal pathogen decolonization; Universal nasal decolonization
General Information
Serial Number | 98437686 |
Word Mark | PROTECT EVERY PATIENT |
Filing Date | Thursday, March 7, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Friday, September 20, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
In Another Form Statement | The mark was first used anywhere in a different form other than that sought to be registered at least as early as |
In Another Form Statement | The mark was first used anywhere in a different form other than that sought to be registered at least as early as |
Goods and Services | Antiseptic solutions; Antiseptic nasal solutions |
In Another Form Statement | The mark was first used anywhere in a different form other than that sought to be registered at least as early as |
In Another Form Statement | The mark was first used anywhere in a different form other than that sought to be registered at least as early as |
Goods and Services | Pathogen colonization reduction consulting services; Staph aureus colonization risk mitigation services; Staph aureus colonization risk management services; MRSA/MSSA colonization risk mitigation services; Infection prevention and control consulting services; Healthcare quality and patient safety consulting services; Universal pathogen decolonization; Universal nasal decolonization |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, July 19, 2024 |
Primary Code | 005 |
First Use Anywhere Date | Tuesday, November 14, 2023 |
First Use In Commerce Date | Thursday, November 30, 2023 |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, July 19, 2024 |
Primary Code | 042 |
First Use Anywhere Date | Friday, June 23, 2023 |
First Use In Commerce Date | Friday, June 23, 2023 |
Trademark Owner History
Party Name | Global Life Technologies Corp. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Bethesda, MD 20814 |
Trademark Events
Event Date | Event Description |
Thursday, March 7, 2024 | NEW APPLICATION ENTERED |
Friday, July 19, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, September 20, 2024 | NON-FINAL ACTION WRITTEN |
Friday, September 20, 2024 | NON-FINAL ACTION E-MAILED |
Friday, September 20, 2024 | ASSIGNED TO EXAMINER |
Friday, September 20, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |